In addition, another study showed that following melanoma-specific CD4+ T cell therapy combined with OX40 co-stimulation or anti-CTLA-4, complete tumour eradication was dependent on neutrophils killing of antigen-negative tumour cells. The gene discussed is CTLA4; the disease is neoplasm.